Caption Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,000
| Closed | -$2.04M | – | 1885 |
|
|
2022
Q3 | $2.04M | Sell |
30,000
-30,000
| -50% | -$1.65M | 0.03% | 637 |
|
|
2022
Q2 | $1.92M | Buy |
60,000
+30,000
| +100% | +$878K | 0.03% | 678 |
|
|
2022
Q1 | $1.04M | Buy |
+30,000
| New | +$897K | 0.01% | 967 |
|
|
2021
Q4 | – | Sell |
-200,000
| Closed | -$5.1M | – | 2069 |
|
|
2021
Q3 | $5.1M | Buy |
200,000
+107,400
| +116% | +$3.16M | 0.06% | 450 |
|
|
2021
Q2 | $3.25M | Buy |
92,600
+67,600
| +270% | +$2.64M | 0.04% | 517 |
|
|
2021
Q1 | $1.02M | Sell |
25,000
-10,000
| -29% | -$460K | 0.02% | 679 |
|
|
2020
Q4 | $1.51M | Sell |
35,000
-37,900
| -52% | -$1.87M | 0.03% | 511 |
|
|
2020
Q3 | $4.02M | Buy |
72,900
+4,900
| +7% | +$311K | 0.09% | 257 |
|
|
2020
Q2 | $4.29M | Buy |
+68,000
| New | +$4.66M | 0.14% | 194 |
|
|
2020
Q1 | – | Sell |
-75,000
| Closed | -$5.96M | – | 1166 |
|
|
2019
Q4 | $5.96M | Sell |
75,000
-65,000
| -46% | -$3.85M | 0.2% | 138 |
|
|
2019
Q3 | $6.79M | Buy |
+140,000
| New | +$7.3M | 0.35% | 69 |
|
|
2019
Q2 | – | Sell |
-20,000
| Closed | -$1.06M | – | 883 |
|
|
2019
Q1 | $1.06M | Buy |
+20,000
| New | +$983K | 0.06% | 342 |
|
|
2018
Q3 | – | Sell |
-15,000
| Closed | -$678K | – | 683 |
|
|
2018
Q2 | $678K | Buy |
+15,000
| New | +$683K | 0.05% | 292 |
|
Other funds holding GBT
Caption Management's GBT Position: Q4 2022 in Review
Caption Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 18,900 shares — an estimated $1.29M sold.
Caption Management first reported a position in GBT in Q2 2018 and held it in 10 quarters. The position peaked at $7.18M in Q2 2021. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Caption Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Caption Management sold 18,900 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.29M.
- Caption Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and held it in 10 quarters.
- Caption Management's Global Blood Therapeutics, Inc. position peaked at $7.18M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.